drugset / Trial / NCT03261193

ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain

NCT03261193

Phase 3 Terminated 21 enrolled Nicholas Schott
RandomizedParallel-groupSingle-blindTreatment

Summary

Comparison of standard post-operative cesarean surgery pain management with regional post-op pain control.

Timeline

Start
2017-09-05
Primary completion
2018-06-25
Completion
2022-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified
Background Morphine Other / unclassified Intrathecal

Indications